endometrial cancer
Showing NaN - NaN of 42
Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)
Recruiting
- Triple Negative Breast Cancer
- +2 more
-
Oklahoma City, Oklahoma
- +1 more
Nov 13, 2023
Endometrial Cancer, Endometrioid Tumor, Cancer Trial in Oklahoma City (nab-sirolimus)
Not yet recruiting
- Endometrial Cancer
- +5 more
-
Oklahoma City, OklahomaUniversity Oklahoma Stephenson Cancer Center
Aug 16, 2023
Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified
Recruiting
- Endometrial Cancer
- +8 more
- Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
-
Orlando, Florida
- +21 more
Feb 2, 2023
Endometrial Cancer Trial in Oklahoma City (Pembrolizumab, Vaginal cuff brachytherapy (VCB), Paclitaxel)
Recruiting
- Endometrial Cancer
- Pembrolizumab
- +3 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
Solid Tumor, Colorectal Cancer, Non Small Cell Lung Cancer Trial in United States (TPST-1495 twice daily, TPST-1495 once daily
Recruiting
- Solid Tumor
- +8 more
- TPST-1495 twice daily
- +2 more
-
Baltimore, Maryland
- +8 more
Jan 4, 2023
Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)
Active, not recruiting
- Advanced Solid Malignancy
- +13 more
-
Los Angeles, California
- +33 more
Dec 22, 2022
Endometrial Cancer Trial in Birmingham, Saint Louis, Oklahoma City (Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
-
Birmingham, Alabama
- +2 more
Nov 21, 2022
Endometrial Cancer Trial in Worldwide (Selinexor, Matching for selinexor)
Active, not recruiting
- Endometrial Cancer
- Selinexor
- Matching placebo for selinexor
-
Tucson, Arizona
- +104 more
Aug 11, 2022
NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +
Active, not recruiting
- Non-Small Cell Lung Cancer
- +12 more
- CPI-006
- +2 more
-
Tucson, Arizona
- +26 more
Aug 1, 2022
Ovarian Cancer, Endometrial Cancer, Cervix Cancer Trial in Oklahoma City (SHetA2)
Recruiting
- Ovarian Cancer
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Jul 7, 2022
Obesity, Endometrial Cancer, Bariatric Surgery Candidate Trial in Oklahoma City (Standard Education, Educational Video)
Not yet recruiting
- Obesity
- +2 more
- Standard Education
- Educational Video
-
Oklahoma City, OklahomaStephenson Cancer Center
May 25, 2022
Breast Cancer, Ovarian Cancer, Endometrial Cancer Trial in Korea, Republic of, United States (FPA150, Pembrolizumab)
Completed
- Breast Cancer
- +3 more
- FPA150
- Pembrolizumab
-
Scottsdale, Arizona
- +17 more
Jan 6, 2022
Uterine Cervical Cancer, Endometrial Cancer Trial in United States (Zalypsis ( PM00104))
Terminated
- Uterine Cervical Cancer
- Endometrial Cancer
- Zalypsis ( PM00104)
-
Boston, Massachusetts
- +3 more
Sep 30, 2021
Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy,
Active, not recruiting
- Endometrial Cancer
- +2 more
- Vaginal Cuff Brachytherapy
- +2 more
-
Oklahoma City, OklahomaStephenson Cancer Center
Aug 13, 2021
Solid Tumors, Ovarian Cancer, Endometrial Cancer Trial in United States (ARQ 092 + carboplatin + paclitaxel (Closed), ARQ 092 +
Terminated
- Solid Tumors
- +2 more
- ARQ 092 + carboplatin + paclitaxel (Closed)
- +2 more
-
Grand Rapids, Michigan
- +4 more
Sep 28, 2020
Endometrial Cancer, Papillary Serous, Clear Cell Endometrial Cancer Trial in Oklahoma City (Vaginal Cuff Brachytherapy)
Completed
- Endometrial Cancer
- +2 more
- Vaginal Cuff Brachytherapy
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Aug 7, 2020
Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Oklahoma City (Mirvetuximab
Withdrawn
- Endometrial Cancer
- +3 more
- Mirvetuximab Soravtansine
- Bevacizumab
-
Oklahoma City, OklahomaStephenson Cancer Center
Jun 25, 2019
Endometrial Cancer Trial in Worldwide (AEZS-108 / zoptarelin doxorubicin, doxorubicin)
Completed
- Endometrial Cancer
- AEZS-108 / zoptarelin doxorubicin
- doxorubicin
-
Phoenix, Arizona
- +122 more
Jul 5, 2018
Endometrial Cancer, Endometrial Tumors Trial in Belgium, United States (XL147 (SAR245408))
Completed
- Endometrial Cancer
- Endometrial Neoplasms
- XL147 (SAR245408)
-
Newport Beach, California
- +12 more
May 9, 2016
Endometrial Cancer, Psychosocial Effects of Cancer and Its Treatment Trial in United States (cisplatin, doxorubicin HCl, low-LET
Completed
- Endometrial Cancer
- Psychosocial Effects of Cancer and Its Treatment
- cisplatin
- +2 more
-
Birmingham, Alabama
- +57 more
Feb 12, 2014